Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago T...
Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'...
Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Mi...
Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Appli...
Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) ...
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...
Singapore: Takeda Pharmaceutical mutually terminated its worldwide agreement with Amylin Pharmaceuticals, which was ori...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a posi...
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...
Singapore: Sucampo Pharmaceuticals' subsidiary SPL has received a $15 million milestone payment from Abbott's subsidiar...
Singapore: Eisai announched that Scotland's health technology assessment (HTA) body, the Scottish Medicines Consortium ...
Singapore: ZOLL Medical, a manufacturer of medical devices and related software solutions and a wholly owned US subsidi...
Singapore: The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Neupro (rotigotine transdermal patch...
Singapore: AVEO Oncology and Astellas Pharma announced that the US Food and Drug Administration (FDA) has accepted fo...
Singapore: Mundipharma has entered a license agreement with Japan-based Shionogi for the exclusive rights to develop, ma...
